Introduction {#section1-2192568219860827}
============

Degenerative cervical myelopathy (DCM) encompasses age-related degenerative changes to the cervical spine, including disc disease, vertebral restructuring, hypertrophy and ossification of intraspinal ligaments, and spondylolisthesis. Together, this set of changes represent the most common cause of spinal cord impairment in adults in industrialized countries.^[@bibr1-2192568219860827]^ There has been considerable interest to investigate the influence of specific pathology, such as ossification of the posterior longitudinal ligament (OPLL), on the clinical presentation, surgical outcome, and surgical approach of patients with DCM in comparison with other pathologies^[@bibr2-2192568219860827],[@bibr3-2192568219860827]^; however, there has been little research investigating patients with cervical spondylolisthesis (CS), which presents in about 12% of patients with DCM^[@bibr4-2192568219860827]^ ([Figure 1](#fig1-2192568219860827){ref-type="fig"}). Outside of DCM, the population prevalence of CS has been estimated to be between 4% and 20%, most commonly occurring at C4-5.^[@bibr5-2192568219860827][@bibr6-2192568219860827][@bibr7-2192568219860827][@bibr8-2192568219860827]-[@bibr9-2192568219860827]^ Although there are subtle differences in the definition of CS, it is identified by anterior or posterior displacement of a rostral vertebra in relation to the adjacent caudal vertebra on static or dynamic radiographic imaging or magnetic resonance imaging (MRI), with translation of 3.0 to 3.5 mm typically representing more severe spondylolisthesis.^[@bibr4-2192568219860827],[@bibr5-2192568219860827],[@bibr10-2192568219860827]^ This displacement can result in considerable instability and may predispose patients to movement dependent or dynamic injury.^[@bibr11-2192568219860827]^ While movement dependent spondylolisthesis and the extent of such movements are typically measured using flexion-extension radiographs or MRI, conventional MRI remains useful in assessing spondylolisthesis in the neutral position.

![Sagittal T2-weighted magnetic resonance images of patients with degenerative cervical myelopathy (DCM) and spondylolisthesis. (A) The patient is presenting with an anterolisthesis of C6. (B) The patient is presenting with a retrolisthesis of C4 and C5.](10.1177_2192568219860827-fig1){#fig1-2192568219860827}

Recently, the prevalence and spectrum of MRI pathologic features in patients surgically treated for DCM was reported using the prospective and multicenter AOSpine North America and International studies.^[@bibr4-2192568219860827]^ Using this data, it is the objective of the current study to report on the clinical presentation and surgical outcome of patients that were identified with CS.

Materials and Methods {#section2-2192568219860827}
=====================

Study Data {#section3-2192568219860827}
----------

The CSM-NA (12 sites in North America) and CSM-I (16 sites in 4 continents: 6 Asian Pacific sites, 5 European sites, 2 sites North America, and 3 sites in South America) were prospective multicenter studies including patients receiving surgical treatment for DCM, together representing a cohort of 757 patients. The primary study results, which focused on the safety and efficacy of surgical treatment, were previously published.^[@bibr12-2192568219860827],[@bibr13-2192568219860827]^ From the cohort, 458 patients had MRIs available for assessment. Patients were enrolled if they were ≥18 years of age, had clinical signs and symptoms of myelopathy, and did not have prior surgery. Neurological and functional impairment was assessed by the mJOA (modified Japanese Orthopaedic Association Assessment Scale),^[@bibr14-2192568219860827]^ Nurick,^[@bibr15-2192568219860827]^ NDI (Neck Disability Index),^[@bibr16-2192568219860827]^ and SF-36 (Short Form--36)^[@bibr17-2192568219860827]^ measures preoperatively and up to 2 years postoperatively. Assessment was supervised by the attending surgeon at each site and the type of surgical treatment and approach was at the discretion of the attending surgeon. External monitors were used to ensure the integrity of the study data, and research ethics board approval was obtained at all participating sites.

MRI Analysis {#section4-2192568219860827}
------------

MRI analysis of both DICOM (digital imaging and communication in medicine) and JPEG files were performed using OsiriX (<http://www.osirix-viewer.com>; Pixmeo, Geneva, Switzerland). Given the multicentered global nature of the study, imaging acquisition techniques differed slightly between sites. However, images were typically acquired using 1.5-T MRI machines with typical slice thickness of 3.0 mm for sagittal imaging and 4.0 mm for transverse imaging on T2-weighted images. Analysis to identify the prevalence of pathology was conducted by the primary author, and the diagnostic criteria and results were previously reported^[@bibr4-2192568219860827]^ ([Table 1](#table1-2192568219860827){ref-type="table"}). The modified K-line measurement was described by Taniyama et al^[@bibr18-2192568219860827]^ and was measured by SK.

###### 

Diagnostic Criteria Used to Identify Specific Pathology on Magnetic Resonance Imaging.^a^

![](10.1177_2192568219860827-table1)

  Diagnosis                                                                 Criteria
  ------------------------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Isolated disc pathology                                                   Single-level disc herniation/bulging disc, with no other disc pathology contributing to spinal cord compression or other levels
  Multilevel disc pathology with or without bone changes (spondylosis)      Spinal cord compression at multiple levels due to multilevel cervical spine degeneration with two or more degenerated discs, with or without associated bone changes
  Ossification of the posterior longitudinal ligament (OPLL)                OPLL appears hypointense on both T1W1 and T2W1. Effacement of the cerebrospinal fluid (CSF) anterior to the cord on T2W1 as well as spinal cord compression that is contiguous across multiple levels, or in the absence of spondylotic changes, is highly suggestive of ligament pathology
  Ligamentum flavum buckling, hypertrophy, calcification, or ossification   Any posterior enlargement of the ligamentum flavum contributing to stenosis of the cervical canal
  Spondylolisthesis or subluxation                                          Anterior or posterior displacement of the vertical body/bodies in relation to adjacent levels on sagittal imaging
  Klippel-Feil syndrome                                                     Vertebral levels without a complete disc and a wasp-waist sign. Absent discs due to degenerative autofusion were disregarded
  Craniocervical junction abnormalities                                     Abnormal structural pathologies resulting in spinal cord or brain stem compression
  Congenital stenosis                                                       Patients with a spinal cord occupation ratio (SCOR) of ≥70% in the spinal canal at nonpathological sites

^a^Taken from Nouri et al (2017).^[@bibr3-2192568219860827],[@bibr4-2192568219860827]^

Spondylolisthesis was identified when there was visible anterior or posterior displacement of a rostral vertebra in relation to the adjacent caudal vertebra on MRI, since lateral or flexion/extension radiographs were not available for all patients. Listhesis was considered present when the entire vertebral body was displaced, rather than solely the edge of the vertebral endplate, to differentiate listhesis from osteophytes. We recognize that utilizing MRI rather than flexion extension radiographs likely underreports patients with movement-dependent spondylolisthesis.

Statistical Analysis {#section5-2192568219860827}
--------------------

Patients with DCM were separated into groups comprising those with and without spondylolisthesis. Continuous variables are presented as means and were compared using independent *t* tests. Categorical variables are presented as proportions and were assessed using chi-square and Fischer's exact tests. Additionally, patients were propensity matched (2 nonspondylolisthesis:1 spondylolisthesis) by age, baseline mJOA, and surgical approach (ie, anterior vs posterior vs combined). This was done because age and baseline mJOA have been shown to be independent predictors of surgical outcome.^[@bibr19-2192568219860827],[@bibr20-2192568219860827]^ In terms of surgical approach, while both anterior and posterior surgery are effective treatment options for DCM, many surgeons prefer a posterior approach for multilevel or more severe disease.^[@bibr3-2192568219860827]^ Surgical approach (anterior vs posterior vs combined) and geographic region were compared using chi-square tests and post hoc pairwise comparisons with Bonferroni correction. A last observation carry-forward approach was used to impute missing data for follow-up at 2 years. After imputation, 436 patients had mJOA, 436 had Nurick, 428 had SF-36, and 363 had NDI outcome data available. Measures of neurological and functional impairment between the groups were compared at baseline and 2 years postoperatively (mean difference from baseline) using independent *t* tests. Multiple linear regression was used to assess the presence of spondylolisthesis, while controlling for age and baseline severity (mJOA), on mJOA recovery ratio. These factors were included as they are known to independently predict surgical outcome.^[@bibr19-2192568219860827],[@bibr21-2192568219860827]^ The mJOA recovery ratio was previously described by Hirabayashi et al^[@bibr22-2192568219860827]^ and is calculated using the formula: (\[postoperative mJOA score -- preoperative mJOA score\]/(18 -- preoperative mJOA score\]) × 100%. Statistical significance was considered at *P* ≤ .05 and tendency toward significance was considered at .05 \< *P* ≤ .10.

Results {#section6-2192568219860827}
=======

Demographics and Clinical Presentation {#section7-2192568219860827}
--------------------------------------

From the cohort of 458 patients (North America, n = 200; Asia, n = 107; Europe, n = 93; Latin America, n = 58), 54 patients presented with CS and 404 had other forms of DCM. The patient demographics in each group are presented in [Table 2](#table2-2192568219860827){ref-type="table"}. Patients with CS were observed to be older by an average of 8.8 years (*P* \< .0001), and presented with worse baseline neurological function as assessed by both the mJOA (11.72 ± 3.05 vs 12.79 ± 2.74, *P* = .008) and Nurick (2.78 ± 1.59 vs 1.74 ± 1.57, *P* = .008), and with worse SF-36 Physical Component Score (PCS) (35.22 ± 9.24 vs 41.23 ± 11.17, *P* = .01). The prevalence of spondylolisthesis varied significantly between regions (*P* = .002, as previously reported),^[@bibr4-2192568219860827]^ and post hoc pairwise comparison after Bonferroni correction showed that spondylolisthesis was significantly less common in Asia (*P* = .0003). Sex, duration of symptoms, SF-36 Mental Component Score (MCS), and NDI were not significantly different (*P* \> .05). On MRI, the prevalence of pathology was mostly comparable between patients presenting with or without CS. However, ligamentum flavum enlargement was considerably more common (81.5% vs 53.5%, *P* \< .0001), the number of compressed levels tended to be more common (3.48 vs 3.08, *P* = .052), and OPLL tended to be less common in patients with spondylolisthesis (3.7% vs 11.4%, *P* = .098).

###### 

Characteristics of DCM Patients With and Without CS.

![](10.1177_2192568219860827-table2)

                                        Spondylolisthesis (n = 54)   Nonspondylolisthesis (n = 404)   *P* ^a^
  ------------------------------------- ---------------------------- -------------------------------- -------------
  Clinical Presentation                                                                               
   Age (years)                          63.9 ± 11.2                  55.1 ± 11.4                      **\<.0001**
   Sex (male)                           57.40%                       62.90%                           .437
   Duration of symptoms (months)        22.8 ± 35.6                  27.7 ± 35.2                      .33
   mJOA                                 11.72 ± 3.05                 12.79 ± 2.74                     **.008**
   Nurick grade                         3.61 ± 1.24                  3.18 ± 1.12                      **.008**
   NDI                                  40.32 ± 18.02 (n = 32)       38.04 ± 20.56 (n = 336)          .46
   SF-36 Mental Component Score         42.06 ± 15.04 (n = 53)       40.21 ± 13.32 (n = 399)          .35
   SF-36 Physical Component Score       31.49 ± 9.82 (n = 53)        35.06 ± 9.37 (n=399)             **.01**
  Region                                                                                              
   North America                        13.5% (n = 27)               86.5% (n = 173)                  **.002**
   Asia^b^                              1.9% (n = 2)                 98.1% (n = 105)                  
   Europe                               18.3% (n = 17)               81.7% (n = 76)                   
   Latin America                        13.8% (n = 8)                86.2% (n = 50)                   
  MRI findings                                                                                        
   Disc herniation                      11.1% (6/54)                 9.2% (37/404)                    .64
   Multilevel disease (spondylosis)     87.0% (47/54)                90.1% (364/404)                  .48
   OPLL                                 3.7% (2/54)                  11.4% (46/404)                   .098^c^
   Ligamentum flavum enlargement        81.5% (44/54)                53.5% (216/404)                  **\<.0001**
   Klippel-Feil syndrome                1.9% (1/54)                  2.0% (8/404)                     1^c^
   CCS/cord-canal mismatch              2.6% (1/38)                  9.2% (25/272)                    .22^c^
   Compressed levels                    3.48 (n = 54)                3.08 (n = 404)                   **.052**
   Modified K-line                      4.11 (n = 52)                4.15 (n = 391)                   .94
   T2WI hyperintensity                  77.4% (41/53)                71% (279/393)                    .33
   T1WI hypointensity                   19.6% (10/51)                19.4% (72/371)                   .97
  Surgical factors                                                                                    
   Operative length                     196.6 ± 89.2                 177.2 ± 75.6                     .087
   Levels operated                      4.3 ± 1.4                    3.6 ± 1.2                        **.0002**
  Surgical approach                                                                                   
   Anterior (n = 265)                   33.3% (18/54)                61.1% (247/404)                  
   Posterior (n = 184)                  61.1% (33/54)                37.4% (151/404)                  **.0002**
   Combined (n = 9)                     5.6% (3/54)                  1.5% (6/404)                     
  Anterior surgery type                                                                               
   Discectomy (n = 202)                 29.4% (15/51)                47.0% (187/398)                  **.018**
   Corpectomy (n = 7)                   2.0% (1/51)                  1.5% (6/398)                     .81
   Discectomy and corpectomy (n = 51)   3.9% (2/51)                  12.3% (49/398)                   .075
  Posterior surgery type                                                                              
   Laminectomy (n = 13)                 11.8% (6/51)                 1.8% (7/398)                     **\<.0001**
   Laminectomy and fusion (n = 110)     47.1% (24/51)                21.6% (86/398)                   **\<.0001**
   Laminoplasty (n = 61)                5.9% (3/51)                  14.6% (58/398)                   .088

Abbreviations: DCM, degenerative cervical myelopathy; CS, cervical spondylolisthesis; OPLL, ossification of the posterior longitudinal ligament; CCS, congenital cervical stenosis; mJOA, modified Japanese Orthopaedic Association Assessment Scale; NDI, Neck Disability Index; SF-36, Short Form--36.

^a^Boldfaced *P* values indicate statistical significance (*P* \< .05).

^b^Was significantly different from other regions (*P* = .0002).

^c^Denotes comparisons made using Fischer's exact test.

After propensity matching, baseline characteristics were comparable between the cohorts with the exception of a marginally statistically significant worse SF-36 PCS among patients with CS (31.5 ± 9.8 vs 34.5 ± 8.4, *P* = .04) ([Table 3](#table3-2192568219860827){ref-type="table"}). The significant difference in the prevalence of ligamentum flavum hypertrophy was no longer present in the matched cohort.

###### 

Characteristics of DCM Patients With and Without CS After Propensity Matching for Age, Baseline mJOA, and Surgical Approach (Anterior, Posterior, Combined).

![](10.1177_2192568219860827-table3)

                                      Spondylolisthesis (n = 54)   Nonspondylolisthesis (n = 108)   *P* ^a^
  ----------------------------------- ---------------------------- -------------------------------- -----------
  Clinical Presentation                                                                             
   Age (years)                        63.9 ± 11.3                  64.1 ± 10.8                      .90
   Sex (male)                         57.41%                       62.04%                           .61
   Duration of symptoms (months)      22.8 ± 35.6                  27.0 ± 37.0                      .49
   mJOA                               11.7 ± 3.0                   11.7 ± 2.6                       .89
   Nurick grade                       3.6 ± 1.2                    3.5 ± 1.2                        .67
   NDI                                40.3 ± 18.0 (n = 50)         37.4 ± 22.0 (n=86)               .43
   SF-36 Mental Component Score       42.1 ± 15.0 (n = 53)         40.2 ± 14.1                      .44
   SF-36 Physical Component Score     31.5 ± 9.8 (n = 53)          34.5 ± 8.4                       **.04**
  MRI findings                                                                                      
   Disc herniation                    11.1% (6/54)                 6.5% (7/108)                     .36
   Multilevel disease (spondylosis)   87.0% (47/54)                93.5% (101/108)                  .23
   OPLL                               3.7% (2/54)                  11.1% (12/108)                   .15
   Ligamentum flavum enlargement      81.5% (44/54)                74.1% (80/108)                   .33
   Klippel-Feil syndrome              1.9% (1/54)                  1.9% (2/108)                     1.00
   CCS/cord-canal mismatch            2.6% (1/38)                  8.6% (6/70)                      .42
   Compressed levels                  3.5 ± 1.4                    3.3 ± 1.2                        .51
   modified K-line                    4.1 ± 3.3 (n = 52)           4.4 ± 2.4 (n = 104)              .48
   T2WI hyperintensity                77.4% (41/53)                81.3% (87/107)                   .68
   T1WI hypointensity                 19.6% (10/51)                29.1% (30/103)                   .24
  Surgical factors                                                                                  
   Operative length                   196.6 ± 89.2                 174.3 ± 7.8                      .11
   Levels operated                    4.3 ± 1.4                    4.0 ± 1.1                        .16
  Surgical approach                                                                                 
   Anterior                           33.3% (18/54)                38.9% (42/108)                   NS
   Posterior                          61.1% (33/54)                58.3% (63/108)                   
   Combined                           5.6% (3/54)                  2.8% (3/108)                     
  Anterior surgery type                                                                             
   Discectomy                         29.4% (15/51)                30.5% (32/105)                   NS
   Corpectomy                         2.0% (1/51)                  1.0% (1/105)                     
   Discectomy and corpectomy          3.9% (2/51)                  8.6% (9/105)                     
  Posterior surgery type                                                                            
   Laminectomy                        11.8% (6/51)                 1.0% (1/[105]{.ul} [)]{.ul}      **\<.01**
   Laminectomy and fusion             47.1% (24/51)                27.6% (29/105)                   **.02**
   Laminoplasty                       5.9% (3/51)                  31.4% (33/105)                   **\<.01**

Abbreviations: DCM, degenerative cervical myelopathy; CS, cervical spondylolisthesis; OPLL, ossification of the posterior longitudinal ligament; CCS, congenital cervical stenosis; mJOA, modified Japanese Orthopaedic Association Assessment Scale; NDI, Neck Disability Index; SF-36, Short Form--36; NS, not significant.

^a^Boldfaced *P* values indicate statistical significance (*P* \< .05).

Surgical Approach {#section8-2192568219860827}
-----------------

Patients with spondylolisthesis were operated on a greater number of levels on average (4.3 ± 1.4 vs 3.6 ± 1.2, *P* = .0002) and tended to have longer operative times than patients without spondylolisthesis (196.6 ± 89.2 vs 177.2 ± 75.6, *P* = .087) ([Table 2](#table2-2192568219860827){ref-type="table"}). There was a statistically significant difference in surgical approach (*P* = .0002), with posterior surgery more common, and anterior surgery less commonly performed in patients with spondylolisthesis than those without. Anterior discectomy was less often chosen for patients with spondylolisthesis (*P* = .018), and the combination of discectomy and corpectomy tended to be less commonly chosen for spondylolisthesis (*P* = .075). There was no difference in the choice for corpectomy. Laminectomy and laminectomy and fusion were both more commonly undertaken in patients with spondylolisthesis than those without (*P* \< .0001). Laminoplasty tended to be more commonly undertaken in patients without spondylolisthesis (*P* = .088).

After propensity matching, the differences in choices for laminectomy (*P* \< .01) and laminectomy and fusion (*P* = .02) remained the same as prior to matching, with both more commonly done in patients with CS ([Table 3](#table3-2192568219860827){ref-type="table"}). However, the choice for undertaking laminoplasty more commonly for patients without CS became significant (*P* \< .01), and the number of levels operated was no longer significantly different.

Surgical Outcome {#section9-2192568219860827}
----------------

Patients with spondylolisthesis had a significantly worse mean neurological improvement in surgical outcome at 2-year follow-up as measured by mJOA (1.5 ± 3.6 vs 2.8 ± 2.7, *P* = .003) and Nurick (−0.8 ± 1.4 vs −1.5 ± 1.5, *P* = .002) compared with patients without spondylolisthesis ([Table 4](#table4-2192568219860827){ref-type="table"}). However, while mean differences in surgical outcome based on the NDI (8.1 ± 20.2 vs 12.8 ± 18.9, *P* = .11), SF-36 PCS (4.1 ± 11.2 vs 6.1 ± 10.8, *P* = .22) and MCS 3.6 ± 15.2 vs 7.0 ± 14.0, *P* = .10) were on average lower for patients with spondylolisthesis, these did not reach statistical significance. After patients with and without CS were propensity matched, the mean improvement of neurological function was still lower in patients with CS (mJOA \[1.5 ± 3.6 vs 3.2 ± 2.8, *P* \< .01\]; Nurick (−0.8 ± 1.4 vs −1.4 ± 1.6, *P* = .02\]). In addition, there was a trend toward worse SF-36 mental recovery among patients with CS (3.6 ± 15.2 vs 8.5 ± 14.4, *P* = .051).

###### 

Difference in Surgical Outcome at 2 Years in Patients With or Without CS Before and After Propensity Matching.
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                              Mean Difference (at 2 Years)   *P* ^a^                 
  --------------------------- ------------------------------ ----------------------- -----------
  Outcome Measure                                                                    
   mJOA (n = 436)             1.5 ± 3.6 (n = 51)             2.8 ± 2.7 (n = 385)     **.003**
   Nurick grade (n = 436)     −0.8 ± 1.4 (n = 51)            −1.5 ± 1.5 (n = 385)    **.002**
   NDI (n = 363)              8.1 ± 20.2 (n = 48)            12.8 ± 18.9 (n = 315)   .11
   SF-36 Mental (n = 428)     3.6 ± 15.2 (n = 51)            7.0 ± 14.0 (n = 377)    .10
   SF-36 Physical (n = 428)   4.1 ± 11.2 (n = 51)            6.1 ± 10.8 (n = 377)    .22
  Propensity Matched Cohort                                                          
   mJOA                       1.5 ± 3.6 (n = 51)             3.2 ± 2.8 (n = 101)     **\<.01**
   Nurick grade               −0.8 ± 1.4 (n = 51)            −1.4 ± 1.6 (n = 101)    **.02**
   NDI                        8.1 ± 20.2 (n = 48)            −12.1 ± 20.2 (n = 79)   .28
   SF-36 Mental               3.6 ± 15.2 (n = 51)            8.5 ± 14.4 (n = 101)    .051
   SF-36 Physical             4.1 ± 11.2 (n = 51)            6.4 ± 11.4 (n = 101)    .24

Abbreviations: CS, cervical spondylolisthesis; mJOA, modified Japanese Orthopaedic Association Assessment Scale; NDI, Neck Disability Index; SF-36, Short Form--36.

^a^Boldfaced *P* values indicate statistical significance (*P* \< .05).

Multiple linear regression to assess the presence of spondylolisthesis on mJOA outcome, controlling for age and baseline mJOA severity, showed that spondylolisthesis was an independent predictor of a lower mJOA recovery ratio (B = −0.190, *P* \< .0001).

Discussion {#section10-2192568219860827}
==========

CS is relatively common in patients with DCM,^[@bibr5-2192568219860827]^ and was present in nearly 12% of patients on MRI in the present cohort. Clinically, these patients presented approximately 9 years older on average, with worse neurological and general functional impairment, a higher rate of ligamentum flavum enlargement, and tended to have more levels of cervical compression than patients without spondylolisthesis. Given these findings, it is not surprising that patients with spondylolisthesis had nearly 1 more cervical level operated on average (4.3 vs 3.6), were more commonly surgically treated from the posterior, and tended to have longer operations. It was notable that despite having this increased severity spectrum, CS presented on average with a 5-month shorter duration of symptoms, and though not statistically significant, it could suggest that these patients may have a more precipitous course owing to potential instability. It was also notable that, on average, patients with CS did not complain of significantly increased neck disability. This is despite the finding of a previous systematic review that neck pain is the first symptom to occur in most patients with degenerative spondylolisthesis.^[@bibr9-2192568219860827]^ Last, as was previously reported,^[@bibr4-2192568219860827]^ patients from the Asian region presented less commonly with spondylolisthesis. This finding may be partially attributable to the high prevalence of OPLL among Asian populations, differences in spinal column size or possibly genetic factors,^[@bibr4-2192568219860827],[@bibr23-2192568219860827]^ which may confer increased cervical stability. However, these suppositions require further investigation.

Surgical Factors and Outcome {#section11-2192568219860827}
----------------------------

In terms of surgical outcome, patients with CS experienced a lower degree of recovery on all measures, but only neurological outcome measures demonstrated a statistically significant difference. While age and baseline neurological severity are known to affect surgical outcome,^[@bibr19-2192568219860827],[@bibr20-2192568219860827],[@bibr24-2192568219860827]^ these were accounted for in the propensity matched cohort and neurological outcome remained suboptimal in the spondylolisthesis cohort. Furthermore, the presence of spondylolisthesis independently affected neurological recovery despite controlling for age and baseline severity on multivariate analysis. It is not entirely clear what causes this influence, but it is possible that spondylolisthesis may exert a more deleterious force upon the spinal cord when it is unstable compared with other forms of DCM whose forces are typically more static in nature. Alternatively, the presentation of spondylolisthesis may simply represent a generally worse degenerative state---this would be supported by the greater number of levels of pathology and the higher rate of circumferential compression which spondylolisthesis patients presented with. However, in terms of T2 hyperintensity presence, there was no statistically significant difference in the prevalence between patients with and without CS.

Before propensity matching, there were more patients without CS that received a discectomy. However, this is likely because of the fact that this group was much younger, making single level disc disease and therefore an ACDF approach much more likely. Indeed, this difference went away after propensity matching, and there was no difference in the approach (anterior vs posterior vs combined). Of note, patients with CS treated posteriorly more commonly received a laminectomy with or without fusion and less commonly a laminoplasty (when looking at posterior surgery only group, patients with CS received a fusion 72.7% (24/33) of the time, while non-CS patients were fused 46% (29/63) of the time). It is possible that this is due to a number of reasons, including regional variations in treatment and surgeon preference. Interestingly, in a recent survey of AOSpine members examining the influence of MRI cervical pathology on surgical decision making in DCM, respondents indicated a moderate to weak preference for an anterior approach if CS is present in isolation.^[@bibr3-2192568219860827]^ However, degenerative CS is often accompanied by other pathological changes, and thus this may indicate the preference for posterior surgery in the present cohort is also dependent on other accompanying factors.

While it seems reasonable that the presence of spondylolisthesis in patients with DCM can have a negative impact on neurological status and outcome, it is interesting that the presence of spondylolisthesis has also shown to be quite benign in patients without myelopathy. Park et al,^[@bibr8-2192568219860827]^ recently showed that the natural history of both cervical anterolisthesis and retrolisthesis appeared to be stable during a follow-up period of up to 8 years. It is challenging to interpret these findings clearly, but this may suggest that the natural history of CS superimposed with other degenerative pathology may represent a different spectrum of pathology than isolated CS.

Comparison With Lumbar Spondylolisthesis {#section12-2192568219860827}
----------------------------------------

Compared to lumbar spondylolisthesis, there has been considerably less focus on CS. However, there have been recent efforts to investigate the topic more extensively. A common point of discussion has been how to define spondylolisthesis and what constitutes stable and unstable.^[@bibr5-2192568219860827],[@bibr8-2192568219860827]^ While the Meyerding classification is a commonly used measure to assess the extent of listhesis,^[@bibr25-2192568219860827]^ the grading is more appropriate for lumbar pathology, as the vast majority of patients with degenerative CS are likely to exhibit only grade I listhesis given the differences in anatomy between the spine regions. In terms of stability, there have been various definitions ranging from at least 2 to 3.5 mm of translation on flexion-extension for identification of instability^[@bibr5-2192568219860827],[@bibr8-2192568219860827],[@bibr9-2192568219860827]^; however, there is no well-defined diagnostic criterion.

Like lumbar spondylolisthesis, disc degeneration and facet arthropathy are the most common causes for spondylolisthesis development. In the lumbar spine, the anatomical orientation of the facet joint can also predispose patients to listhesis,^[@bibr26-2192568219860827]^ and it is possible that certain anatomical variations, including congenital anomalies or facet tropism in the cervical region, may likewise affect potential listhesis development. Furthermore, sagittal alignment may have an impact on listhesis development and has been suggested to predispose listhesis in the lumbar region.^[@bibr26-2192568219860827]^ Interestingly, randomized control studies assessing surgical outcomes have been unable to determine whether fusion is definitively better than nonfusion surgery for lumbar stenosis, and therefore it is not clear whether this would be true for the cervical region as well.^[@bibr27-2192568219860827],[@bibr28-2192568219860827]^ Last, lumbar spine stenosis patients with or without spondylolisthesis appear to have similar baseline impairment (Oswestry Disability Index \[ODI\], EQ5D) and improvement after surgery.^[@bibr27-2192568219860827],[@bibr29-2192568219860827]^ It is challenging to directly compare these results with CS, as the findings of the present study indicate that patients with CS appear to have suboptimal neurological recovery based on myelopathy specific measures, and not EQ5D or ODI. While the CS patients here did have less recovery on the SF scales (which would be the most relevant comparison to EQ5D/ODI), these were not significantly different from non-CS and thus perhaps suggest a marginal but insignificant difference in health quality outcomes, as appears to be the case with lumbar stenosis.

Limitations {#section13-2192568219860827}
-----------

We assessed patients for CS using conventional MRIs, as we did not have flexion/extension radiographs for all patients, DICOM formats were not available for some radiographs, and due to inconsistent acquisition techniques among different centers. Also, there was some minor variability in MRI acquisition techniques given that images were obtained from multiple centers, including differences in slice thickness and magnet type (Tesla strength). While this results in subtle differences between the images, we believe that this factor had a relatively minor impact with regard to CS diagnosis. Another limitation to consider is that our findings are restricted to those patients with spondylolisthesis apparent on static imaging in a supine position, which we recognize will miss some cases of dynamic spondylolisthesis. Furthermore, patients were identified for the presence or absence of spondylolisthesis and therefore, we have not reported the degree of translation or whether the patients had anterolisthesis or retrolisthesis. However, most patients had anterolisthesis, and breaking this population down would have not provided enough patients for adequate statistical analysis. Future work will focus on the assessment of spondylolisthesis using flexion and extension radiographs, which offers the opportunity to discover both static and movement dependent vertebra translocation, the degree of translation, and stability. In addition, it would be useful in future analysis to investigate the status of the facet joint in greater detail. Furthermore, only 1 rater reviewed the presence of pathology based on the criteria previously published, and 1 rater reviewed the modified K-line. In terms of the type of pathology in the geographic regions, while multiple centers were involved, it is unclear if inclusion in the study by centers was affected by selection bias, and therefore findings such as low spondylolisthesis occurrence in Asia may have been encountered spuriously.

Conclusion {#section14-2192568219860827}
==========

CS presents more commonly in older patients with DCM and manifests with worse baseline neurological function and quality of life. These patients typically have compression arising from both the anterior and posterior, have more levels of spinal cord compression, and receive surgery on a greater number of cervical levels that is more commonly performed with a posterior approach. Furthermore, while these patients experience an average improvement of about 1.5 points on the mJOA scale at 2-year follow-up, this is significantly lower than the improvement experienced by other DCM patients without spondylolisthesis. Overall, these findings suggest that the presence of CS may indicate a more advanced state of DCM pathology and is more likely to result in a suboptimal surgical outcome. However, further studies are needed to evaluate other potential factors relevant to CS such as facet hypertrophy, fluid signal in the facet joints, and stable and unstable CS.
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